Overview
Uniqsis designs and manufactures benchtop continuous flow chemistry systems for pharmaceutical R&D and chemical synthesis. Their modular reactors, including FlowSyn and FlowLab, support scalable reactions from mg to kg scale, high temperatures up to 300°C, and pressures to 1400 psi. These systems enable automated, efficient processes for catalysis, library synthesis, and superheated reactions used by major pharma companies.
Frequently asked questions
- What flow chemistry systems does Uniqsis offer?
- Uniqsis offers modular systems like FlowSyn (fully integrated benchtop reactor), FlowLab (affordable entry-level with manual/automated control), and FlowLab Column (2-channel for high-temperature/pressure catalysis), supporting reactions from ambient to 300°C and up to 1400 psi.
- What capabilities do Uniqsis reactors provide for pharma R&D?
- Systems handle extensive chemistries from mg to kg scale, including microwave-like conditions up to 260°C, sub-ambient cooling to -70°C, automation for multi-step sequences, and library synthesis, designed by chemists for efficiency and scalability.
- What industries and regions use Uniqsis equipment?
- Uniqsis FlowSyn is used by major pharmaceutical companies and academic labs worldwide for continuous flow chemistry; distributors like Interchim (Europe) and Asynt support global access.